Andrew Ross, MD
NPI 1992708242 · Ophthalmology Physician · Austin, TX
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1992708242
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- L9878 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
21 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
765 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Problem Focused Exam of Visual System92012 | 359 | $92 |
| Established Patient Complete Exam of Visual System92014 | 228 | $129 |
| Imaging of Retina92134 | 54 | $42 |
| Exam of Visual Field With Extended Testing92083 | 48 | $65 |
| Imaging of Optic Nerve92133 | 43 | $35 |
| New Patient Complete Exam of Visual System92004 | 33 | $153 |
Typical Medicare-allowed amounts for these services range $35–$153 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 179 | 39 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 89 | 84 |
| Prednisolone Acetate | 35 | 30 |
| Timolol Maleate | 24 | — |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 21 | — |
| Brimonidine Tartrate/Timololbrand: Brimonidine Tartrate-Timolol | 20 | — |
| Bimatoprostbrand: Lumigan | 17 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$340 across 14 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-05-31
- Last updated
- 2011-09-13
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.